Login

John Lai, CEO/President of PetVivo Holdings, Inc., discusses game-changing innovations in a segment interview. 00:10:00

Share On Facebook Share On Twitter

John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
investing in the worlds most disruptive companies|Dinesh Katiyar,Partner,Accel
00:10:00
Peloton Minerals CEO Ted Elwood Discusses Exploration Focus and Upcoming Catalysts
00:10:00
Bonterra Resources: Exploration and Development Update
00:10:00
Darren Hazelwood Discusses Panther Metals' Dotted Lake Drilling Program in Ontario | Darren Hazelwood, CEO, Panther Metals Ltd.
00:10:00
Madryn Asset Management is a leading alternative asset management firm that invests in innovative healthcare companies specializing in unique and transformative products, technologies, and services. The firm draws on its extensive and diverse experience s
00:10:00
Discovering Untapped Gold Potential in South Korea: A Unique Mining Frontier
00:10:00
SBuilding Global Bridges: The Success Behind L Catterton's Strategic Merger | Michael Chu, Global co-CEO ,  L Catterton.
00:10:00
Firm does not invest in Hardware, CPG, or Biotech/Life Sciences|Ed Roman,Managing Director, Hack VC
00:10:00
Graeme Bevans, Managing Director and CEO of Atlas Arteria (ASX:ALX), presents during the August 2020 Reporting Season.|Graeme Bevans is an Executive Director of ATLAX
00:10:00
VENTENY's Journey to Becoming the 59th Company Listed on the Indonesia Stock Exchange (IDX) | Damar Raditya, COO, PT Venteny Fortuna International.
00:10:00
"Discover the forward-thinking perspectives of John Lai, CEO & President of PetVivo Holdings, Inc., in a captivating interview exploring the company's innovative journey."|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:10:00
Inside AABC: H.B. Fuller's Expert Interviews | Celeste Mastin - CEO of H.B. Fuller

© 2026 Nehu